Safety Study of Inactivated Shigella Whole Cell Vaccine in Adults

Conditions

• Shigellosis

Interventions

• BIOLOGICAL: Vaccine: 2.6±0.8 x 10^8 vp/mL, 1 dose
• BIOLOGICAL: Vaccine: 2.6±0.8 x 10^9 vp/mL, 3 doses
• BIOLOGICAL: Vaccine: 2.6±0.8 x 10^10 vp/mL, 3 doses
• BIOLOGICAL: Vaccine: 2.6±0.8 x 10^11 vp/mL, 3 doses
• BIOLOGICAL: Placebo: 1-3 doses

Sponsor

PATH